| 000 | 01557 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517054542.0 | ||
| 264 | 0 | _c20160815 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1473-5687 | ||
| 024 | 7 |
_a10.1097/MEG.0000000000000470 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVolonaki, Eleni | |
| 245 | 0 | 0 |
_aAdalimumab as a second-line biological therapy in children with refractory ulcerative colitis. _h[electronic resource] |
| 260 |
_bEuropean journal of gastroenterology & hepatology _cDec 2015 |
||
| 300 |
_a1425-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdalimumab _xadministration & dosage |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aColectomy |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aDrug Evaluation _xmethods |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfliximab _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 700 | 1 | _aMutalib, Mohamed | |
| 700 | 1 | _aKiparissi, Fevronia | |
| 700 | 1 | _aShah, Neil | |
| 700 | 1 | _aLindley, Keith J | |
| 700 | 1 | _aElawad, Mamoun | |
| 773 | 0 |
_tEuropean journal of gastroenterology & hepatology _gvol. 27 _gno. 12 _gp. 1425-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MEG.0000000000000470 _zAvailable from publisher's website |
| 999 |
_c25315404 _d25315404 |
||